P Névot

552 total citations
35 papers, 457 citations indexed

About

P Névot is a scholar working on Molecular Medicine, Molecular Biology and Pharmacology. According to data from OpenAlex, P Névot has authored 35 papers receiving a total of 457 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Medicine, 9 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in P Névot's work include Antibiotic Resistance in Bacteria (17 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). P Névot is often cited by papers focused on Antibiotic Resistance in Bacteria (17 papers), Antibiotic Use and Resistance (7 papers) and Antibiotics Pharmacokinetics and Efficacy (5 papers). P Névot collaborates with scholars based in France. P Névot's co-authors include Paul Geertsema, A. Philippon, G. Baranton, D. Postic, Marc V. Assous, L Gilly, Roger Labia, A. Belaaouaj, G. Vedel and G. Fournier and has published in prestigious journals such as The Journal of Infectious Diseases, Journal of Antimicrobial Chemotherapy and FEMS Microbiology Letters.

In The Last Decade

P Névot

33 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Névot France	11	220	137	127	90	82	35	457
Efstathia Scoulica Greece	13	90 0.4×	119 0.9×	103 0.8×	20 0.2×	215 2.6×	17	566
Kyriaki Xanthopoulou Germany	15	295 1.3×	63 0.5×	348 2.7×	64 0.7×	64 0.8×	33	720
Ivan Ivanov Bulgaria	12	109 0.5×	59 0.4×	88 0.7×	20 0.2×	87 1.1×	49	456
Lurdes Clemente Portugal	16	303 1.4×	37 0.3×	108 0.9×	32 0.4×	27 0.3×	28	480
Guangwu Lu China	9	113 0.5×	68 0.5×	80 0.6×	14 0.2×	23 0.3×	11	334
T. L. Skogerboe United States	13	40 0.2×	35 0.3×	80 0.6×	124 1.4×	81 1.0×	27	485
Inga Ruddat Germany	11	117 0.5×	42 0.3×	80 0.6×	22 0.2×	17 0.2×	22	310
Marvin A. Villanueva Philippines	9	90 0.4×	111 0.8×	85 0.7×	9 0.1×	33 0.4×	17	314
S. Jalal Sweden	6	100 0.5×	54 0.4×	151 1.2×	20 0.2×	181 2.2×	6	372
Margaret Whipp Australia	13	69 0.3×	223 1.6×	197 1.6×	16 0.2×	56 0.7×	20	658

Countries citing papers authored by P Névot

Since Specialization

Citations

This map shows the geographic impact of P Névot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Névot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Névot more than expected).

Fields of papers citing papers by P Névot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Névot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Névot. The network helps show where P Névot may publish in the future.

Co-authorship network of co-authors of P Névot

This figure shows the co-authorship network connecting the top 25 collaborators of P Névot. A scholar is included among the top collaborators of P Névot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Névot. P Névot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Névot, P, et al.. (1996). [LOCAL TREATMENT OF PULMONARY ASPERGILLOMA WITH TRANSPARIETAL INJECTIONS OF AMPHOTERICIN B].. PubMed. 18. 789–98. 5 indexed citations

Gilly, L, et al.. (1995). [Resistance to amoxicillin and amoxicillin-clavulanic acid combination of 231 clinical strains of Escherichia coli, isolated in 1992 at the Cochin Hospital].. PubMed. 43(9). 760–5. 12 indexed citations

Assous, Marc V., D. Postic, Paul Geertsema, P Névot, & G. Baranton. (1993). Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of theBorrelia strains used as antigens. European Journal of Clinical Microbiology & Infectious Diseases. 12(4). 261–268. 136 indexed citations

Belaaouaj, A., L Gilly, Roger Labia, et al.. (1992). Clinical isolates of Escherichia coli producing TRI β-lactamases: novel TEM-enzymes conferring resistance to β-lactamase inhibitors. Journal of Antimicrobial Chemotherapy. 30(4). 449–462. 94 indexed citations

Philippon, A., et al.. (1990). Susceptibility ofAlcaligenes denitrificans subspeciesxylos-oxydans to beta-lactam antibiotics. European Journal of Clinical Microbiology & Infectious Diseases. 9(6). 405–409. 9 indexed citations

Vedel, G., Bertrand Picard, Paul Geertsema, et al.. (1989). Analysis of the molecular relatedness of four extended spectrum β-lactamases (SHV-2, SHV-3, SHV-4 and SHV-5) by comparative protein titration curves. Journal of Antimicrobial Chemotherapy. 24(1). 9–17. 15 indexed citations

Vedel, G., Bertrand Picard, Paul Geertsema, et al.. (1989). The analysis of five carbenicillin-hydrolysing enzymes by electrophoretic methods. Research in Microbiology. 140(7). 579–590. 4 indexed citations

Geertsema, Paul, Michel Barthélémy, A. Philippon, et al.. (1988). Immunological comparison of constitutive β-lactamases of gram-negative bacteria by neutralization in zymogram gels: Properties of anti-TEM-1 and anti-TEM-2 sera. Annales de l Institut Pasteur Microbiologie. 139(4). 435–451. 13 indexed citations

Vedel, G., Bertrand Picard, Paul Geertsema, et al.. (1987). [Titration curves of beta-lactamases using pH gradient electrophoresis].. PubMed. 35(5 Pt 2). 699–701. 2 indexed citations

10.

Philippon, A., B Joly, Dénis Reynaud, et al.. (1986). Characterization of a β-lactamase from Pasteurella multocida. Annales de l Institut Pasteur Microbiologie. 137(1). 153–158. 15 indexed citations

11.

Philippon, A., Paul Geertsema, & P Névot. (1986). [Mechanism of enzymatic resistance to beta-lactam antibiotics].. PubMed. 15(46). 2290–6. 4 indexed citations

12.

Choudat, D., Christian Le Goff, Paul Geertsema, et al.. (1985). Sérodiagnostic des infections respiratoires à Pasteurella multocida. Agritrop (Cirad). 1 indexed citations

13.

Philippon, A., A Thabaut, M Meyran, & P Névot. (1984). [Distribution of constituent beta-lactamases in Pseudomonas aeruginosa].. PubMed. 13(13). 772–6. 14 indexed citations

14.

Philippon, A., Paul Geertsema, & P Névot. (1981). Comparative in-vitro activity of cefsulodin and ceftazidime against ticarcillin-resistant Pseudomonas aeruginosa. Journal of Antimicrobial Chemotherapy. 8(suppl B). 119–122. 8 indexed citations

15.

Philippon, A., Paul Geertsema, Michel Barthélémy, et al.. (1980). Properties of the beta-lactamase (penicillinase) produced byLevinea malonatica. FEMS Microbiology Letters. 8(4). 191–194. 10 indexed citations

16.

Paul, Gregory S., et al.. (1977). [Pork-butcher's meningitis].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 6(40). 3749–3749. 3 indexed citations

17.

Philippon, A., et al.. (1977). Rifampin in the Treatment of Experimental Brucellosis in Mice and Guinea Pigs. The Journal of Infectious Diseases. 136(4). 482–488. 28 indexed citations

18.

Philippon, A., A Kazmierczak, M Plommet, J Marly, & P Névot. (1976). [Treatment of experimental brucellosis of mice and guinea pigs by rifampicin].. PubMed. 31. 279–86. 2 indexed citations

19.

Névot, P, et al.. (1975). [Bacteria and bile].. PubMed. 4 Suppl 1. 35–8. 2 indexed citations

20.

Parienté, R, et al.. (1966). [Clinical trials of D. A. T.(4,4'-di-iso-amyloxy-thio-carbanilide) in common human pulmonary tuberculosis].. PubMed. 30(12). 1205–20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact